Abstract

ALPHALISA BIOMARKER AS A TOOL OF DRUG DISCOVERY AND DEVELOPMENT

Biomarkers have been identified as “cellular, biochemical, or molecular alterations that are measurable in biological media such as human tissue, cells, or fluids.” Biomarkers like prognostic Biomarker, Diagnostic Biomarker, Mechanism of action Biomarker, Surrogate Biomarker have important role in Drug Development. In preclinical stage discovery biomarker used which may not be the same Biomarker used after the drug is selected to enter clinical trials. In Alphalisa technology biomarker does not require wash steps and it has High-throughput screening.


Author(s): Kaumil N. Modi, Palak K. Parikh and Prof. Dr. Dhrubo Jyoti Sen

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Recommended Conferences
Flyer image
Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • MIAR
  • ResearchGate
  • University Grants Commission
  • Secret Search Engine Labs

tempobet

tempobet giriş

tempobet giriş

tipobet süpertotobet yeni adres süperbahis 747 güvenilir bahis siteleri telefonda sex sohbet